emu Regional Benefits Study Advancing
Filed with ASX · · 3 pages · English
Summary by 6ix AI
EMvision Medical Devices Ltd. reports on the progress of its emu Regional Benefits Study, highlighting the completion of site visits and the advancement of study protocols. The study aims to demonstrate the clinical benefits of the emu bedside scanner in regional hospitals lacking CT access, with a focus on improving stroke diagnosis. A progress payment has been received under the Cooperative Research Centres Projects program, supporting the study's objectives. Next steps include finalizing the study protocol and obtaining necessary approvals for further site inclusion.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- emu Pivotal Trial Recruitment Surpasses 200 Patients
- Appendix 4E & Annual Report to 30 June 2026
- Aeromedical Study De-Risks Rural & Remote Stroke Use Cases
- EMVision to Receive $1.17M IGP Grant Instalment
- emu Pivotal Trial Expansion Adds Acute Ischaemia Detection
Later from EMvision Medical Devices
- First Responder Successfully Trialled with MSU
- $4.3m Non-Dilutive R&D Tax Rebate Received
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices